Collegium Pharmaceutical (COLL) Inventory (2016 - 2026)

Collegium Pharmaceutical's Inventory history runs 11 years deep, the most recent figure standing at $42.7 million for Q1 2026.

• In Q1 2026, Inventory rose 14.84% year-over-year to $42.7 million; the TTM figure through Mar 2026 stood at $42.7 million (up 14.84% YoY), while the FY2025 annual figure was $40.9 million, up 15.05% from the prior year.
• Inventory was $42.7 million for Q1 2026 at Collegium Pharmaceutical, up from $40.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $80.1 million in Q1 2022 to a low of $26.0 million in Q2 2023.
• Historically, Inventory has averaged $42.6 million across 5 years, with a median of $38.0 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Inventory jumped 417.14% in 2022, then sank 66.53% in 2023.
• A 5-year view of Inventory shows it stood at $46.5 million in 2022, then plunged by 30.47% to $32.3 million in 2023, then increased by 9.98% to $35.6 million in 2024, then increased by 15.05% to $40.9 million in 2025, then rose by 4.47% to $42.7 million in 2026.
• The last three Inventory figures came in at $42.7 million (Q1 2026), $40.9 million (Q4 2025), and $38.1 million (Q3 2025), per Business Quant data.